STRATA Skin Sciences (SSKN) Competitors $2.67 -0.04 (-1.62%) As of 03/28/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SSKN vs. SPAI, DXR, BDMD, FEMY, CLGN, POCI, NXL, NMTC, PYPD, and DRIOShould you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include Safe Pro Group Inc. Common Stock (SPAI), Daxor (DXR), Baird Medical Investment (BDMD), Femasys (FEMY), CollPlant Biotechnologies (CLGN), Precision Optics (POCI), Nexalin Technology (NXL), NeuroOne Medical Technologies (NMTC), PolyPid (PYPD), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry. STRATA Skin Sciences vs. Safe Pro Group Inc. Common Stock Daxor Baird Medical Investment Femasys CollPlant Biotechnologies Precision Optics Nexalin Technology NeuroOne Medical Technologies PolyPid DarioHealth Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, community ranking, media sentiment, dividends, profitability and analyst recommendations. Is SPAI or SSKN more profitable? Safe Pro Group Inc. Common Stock has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -28.72%. Safe Pro Group Inc. Common Stock's return on equity of 0.00% beat STRATA Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Safe Pro Group Inc. Common StockN/A N/A N/A STRATA Skin Sciences -28.72%-69.33%-17.55% Do analysts prefer SPAI or SSKN? STRATA Skin Sciences has a consensus price target of $6.00, suggesting a potential upside of 123.05%. Given STRATA Skin Sciences' stronger consensus rating and higher possible upside, analysts clearly believe STRATA Skin Sciences is more favorable than Safe Pro Group Inc. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Safe Pro Group Inc. Common Stock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00STRATA Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in SPAI or SSKN? 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to SPAI or SSKN? In the previous week, STRATA Skin Sciences had 16 more articles in the media than Safe Pro Group Inc. Common Stock. MarketBeat recorded 17 mentions for STRATA Skin Sciences and 1 mentions for Safe Pro Group Inc. Common Stock. Safe Pro Group Inc. Common Stock's average media sentiment score of 1.90 beat STRATA Skin Sciences' score of 0.18 indicating that Safe Pro Group Inc. Common Stock is being referred to more favorably in the media. Company Overall Sentiment Safe Pro Group Inc. Common Stock Very Positive STRATA Skin Sciences Neutral Which has better earnings and valuation, SPAI or SSKN? Safe Pro Group Inc. Common Stock has higher earnings, but lower revenue than STRATA Skin Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSafe Pro Group Inc. Common Stock$1.56M23.39N/AN/AN/ASTRATA Skin Sciences$32.68M0.34-$10.83M-$2.66-1.01 Does the MarketBeat Community prefer SPAI or SSKN? STRATA Skin Sciences received 224 more outperform votes than Safe Pro Group Inc. Common Stock when rated by MarketBeat users. CompanyUnderperformOutperformSafe Pro Group Inc. Common StockN/AN/ASTRATA Skin SciencesOutperform Votes22464.00% Underperform Votes12636.00% SummarySTRATA Skin Sciences beats Safe Pro Group Inc. Common Stock on 8 of the 13 factors compared between the two stocks. Remove Ads Get STRATA Skin Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SSKN vs. The Competition Export to ExcelMetricSTRATA Skin SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.22M$4.35B$5.63B$7.84BDividend YieldN/A48.03%5.33%4.01%P/E Ratio-1.0128.4223.5118.72Price / Sales0.3449.24388.1990.75Price / CashN/A51.0838.1734.64Price / Book0.746.116.894.23Net Income-$10.83M$67.64M$3.20B$247.47M7 Day Performance0.37%-5.25%-3.06%-2.29%1 Month Performance1.89%-4.12%1.51%-5.81%1 Year Performance-28.84%10.65%9.35%-0.94% STRATA Skin Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SSKNSTRATA Skin Sciences2.8918 of 5 stars$2.69-0.7%$6.00+123.0%-28.8%$11.22M$32.68M-1.01120Earnings ReportShort Interest ↑News CoverageGap DownSPAISafe Pro Group Inc. Common StockN/A$2.94+0.7%N/AN/A$40.45M$1.56M0.0011Positive NewsDXRDaxor4.0778 of 5 stars$8.15-2.2%$25.00+206.7%-9.8%$39.42M$2.13M0.0037Gap UpBDMDBaird Medical InvestmentN/A$5.67-1.6%N/AN/A$37.33M$33.05M0.00N/AFEMYFemasys2.2743 of 5 stars$1.56-2.5%$11.50+637.2%-16.8%$35.72M$1.26M-1.9330Earnings ReportAnalyst ForecastShort Interest ↑News CoverageCLGNCollPlant Biotechnologies2.8416 of 5 stars$3.11+0.3%$12.50+301.9%-52.3%$35.63M$650,000.00-2.0270Earnings ReportAnalyst ForecastShort Interest ↓News CoverageHigh Trading VolumePOCIPrecision Optics0.3225 of 5 stars$4.41-6.7%N/A-25.6%$33.69M$18.68M-6.8980Short Interest ↑News CoverageNXLNexalin Technology3.2516 of 5 stars$2.34-1.7%$5.00+113.7%+36.4%$31.13M$168,721.00-3.663Short Interest ↓Positive NewsGap UpNMTCNeuroOne Medical Technologies0.8213 of 5 stars$0.97-5.8%N/A-28.3%$29.94M$5.75M-3.7320Short Interest ↓Positive NewsPYPDPolyPid2.7406 of 5 stars$2.94+4.4%$11.33+286.1%-40.4%$29.91MN/A-0.5980Short Interest ↓DRIODarioHealth2.7894 of 5 stars$0.70+1.7%$1.50+114.3%-59.3%$29.10M$27.04M-0.74200 Remove Ads Related Companies and Tools Related Companies Safe Pro Group Inc. Common Stock Alternatives Daxor Alternatives Baird Medical Investment Alternatives Femasys Alternatives CollPlant Biotechnologies Alternatives Precision Optics Alternatives Nexalin Technology Alternatives NeuroOne Medical Technologies Alternatives PolyPid Alternatives DarioHealth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SSKN) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share STRATA Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.